Tariff Impact Series: Reshaping Global Healthcare
Visiongain’s Tariff Impact Series delivers critical insights into how recent trade and tariff policies are disrupting the pharmaceutical, biotech, and medical industries.
This special first edition explores how tariffs affect drug access, clinical trial economics, and supply chain dynamics.
What You’ll Learn:
- Timeline of key tariff announcements
- Global supply chains at risk
- Latest policy signals from trade talks
- Strategic risks for generics and device manufacturers
- Scenario models on drug affordability and reshoring barriers
- Insight from global CEOs and industry leaders
Discover More. Decide Smarter.
With over 25 years of research expertise, Visiongain equips decision-makers with trusted intelligence to act faster and smarter.
